))
Sarcoidosis: Disparities in Healthcare & the Importance of Diversity in Clinical Trials
Manage episode 345750340 series 2923408
コンテンツは Ronda F Jefferson によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Ronda F Jefferson またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Photo Credit - pulmonaryhypertensionnews.com
In this episode, I will be interviewing Dr. Divya Patel. She works closely with Sarcoidosis patients and the work that she and so many other doctors do is important for recognition of this terrible disease. I have seen this disease first-hand. Ten years ago, my sister died from complications from one of the forms of sarcoidosis.
It is extremely important that clinical trials are performed in order to advance the treatment of not only sarcoidosis, but all rare diseases. Just as important is to make sure that all people are represented. Black people are significantly underrepresented in clinical trials, not only in the U.S. but in many other countries. We will be discussing what these trials are and why it is so important to have all people represented.
"Dr. Patel is a Clinical Associate Professor of Pulmonology and Director of the Sarcoidosis and ILD Programs at the University of Florida. The focus of her career is to improve the care of patients who are critically ill and have chronic pulmonary conditions such as sarcoidosis and interstitial disease. She has a special interest in understanding how sarcoidosis affects patients from underrepresented backgrounds and the obstacles they face in accessing care. Having completed specialized training, she participates in clinical research with the aim to improve the quality of life of patients."
Important Resources:
http://www.stopsarcoidosis.org/ACTNow (Survey)
http://www.stopsarcoidosis.org.
https://www.lung.org/lung-health-diseases/lung-disease-lookup/sarcoidosis
https://www.nhlbi.nih.gov/health/sarcoidosis
www.rarediseases.org
54 つのエピソード
シェア
